Tango Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
201 Brookline Ave Ste 901, Boston, Massa...Phone Number
(857) 320-4900Website
www.tangotx.comRevenue
$57 MillionStock Symbol
TNGXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
3
1
2
2
2
1
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company focused on discovering and developing precision oncology therapies. The company leverages genetic insights and targeted drug discovery to develop novel cancer treatments for genetically defined patient populations with significant unmet medical needs.Explore more
Tango Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tango Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Tango Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Tango Therapeutics has new funding data
Earning: See what the market has to say on Tango Therapeutics recently announced quarterly report
Tango Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Tango Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Tango Therapeutics had a recent Job posting/layoffs
Check if Tango Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Tango Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined Tango Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Tango Therapeutics
Compare insights from companies similar to Tango Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Tango Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Tango Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Tango Therapeutics.
Tango Therapeutics financials insights
Gather financial insights about Tango Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Private Equity
$50M
Other Financing Round
$165M
2025
Stock/Share Issuance
$225M
Stock/Share Issuance
$15M
Tango Therapeutics Tech Stack
A closer look at the technologies used by Tango Therapeutics
See more technologies
Most Recent Scoops
Open Position
Open Position
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Open Position
Tango Therapeutics News & Media
Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) (“Tango Therapeutics” or the “Company”) today announced that members of the management team are scheduled to participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Wednesday, September 9, 2026 at 8:35 AM EDT.Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
Company continues to prepare for late-stage clinical advancement of vopimetostat in combination with daraxonrasib for pancreatic cancer following positive Phase 1/2 dataTango Therapeutics Announces Executive Chair Transition
BOSTON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Dr. Barbara Weber, the Executive Chairman of the Board of Directors of Tango Therapeutics, will be stepping down in connection with other pursuits.Tango Therapeutics Appoints Robert Azelby to Board of Directors
BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced the appointment of Robert Azelby to its Board of Directors. Mr. Azelby brings more than three decades of leadership experience across the biopharmaceutical industry, including deep expertise in oncology commercialization, corporate strategy, company building and board go
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Tango Therapeutics
Sign Up For FreeTo access detailed company insights
Tango Therapeutics is a clinical-stage biotechnology company focused on discovering and developing precision oncology therapies. The company leverages genetic insights and targeted drug discovery to develop novel cancer treatments for genetically defined patient populations with significant unmet medical needs.... Read More
